<?xml version="1.0" encoding="UTF-8"?>
<document>
<type>mainstream</type>
<forum>http://investor.biospace.com/biospace/action/rssfeed?ChannelID=3223</forum>
<forum_title>ChinaBio® Today</forum_title>
<discussion_title>Ascentage Collaborates with UNITY on Treatments to Clear Senescent Cells</discussion_title>
<language>english</language>
<gmt_offset></gmt_offset>
<topic_url>http://investor.biospace.com/biospace/news/read?GUID=31966943</topic_url>
<topic_text>
April 25, 2016 at 05:17 AM EDT Ascentage Collaborates with UNITY on Treatments to Clear Senescent Cells Ascentage Pharma of Shanghai will collaborate with San Francisco&apos;s UNITY Biotechnology using Acentage&apos;s apoptosis molecules to develop anti-senescence treatments for age-related disease. A clinical-stage biopharma, Ascentage has developed a library of small-molecule apoptosis molecules for oncology indications. UNITY is focused on developing drugs that clear senescent cells as treatments for age-related disease. Each company will make an investment in the other, though details were not disclosed. They will also form a JV to market senescence treatments in China. Ascentage will be attending the ChinaBio® Partnering Forum, May 18-19 in Suzhou. More details.... Share  
</topic_text>
<spam_score>0.00</spam_score>
<post_num>1</post_num>
<post_id>post-1</post_id>
<post_url>http://investor.biospace.com/biospace/news/read?GUID=31966943</post_url>
<post_date>20160425</post_date>
<post_time>0917</post_time>
<username></username>
<post>
April 25, 2016 at 05:17 AM EDT Ascentage Collaborates with UNITY on Treatments to Clear Senescent Cells Ascentage Pharma of Shanghai will collaborate with San Francisco&apos;s UNITY Biotechnology using Acentage&apos;s apoptosis molecules to develop anti-senescence treatments for age-related disease. A clinical-stage biopharma, Ascentage has developed a library of small-molecule apoptosis molecules for oncology indications. UNITY is focused on developing drugs that clear senescent cells as treatments for age-related disease. Each company will make an investment in the other, though details were not disclosed. They will also form a JV to market senescence treatments in China. Ascentage will be attending the ChinaBio® Partnering Forum, May 18-19 in Suzhou. More details.... Share  
</post>
<signature>

</signature>
<external_links>

</external_links>
<country>US</country>
<main_image></main_image>
</document>
